Compare Indomobil Sukses Internasional Tbk. (IMAS) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indomobil Sukses Internasional Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Indomobil Sukses Internasional Tbk. trades at Rp860 (market cap 3.36T, 31.7K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: Indomobil Sukses Internasional Tbk. is far larger — about 5.2× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (848.2K versus 31.7K). Which is the better fit depends on your goals.
| IMAS | LABS | |
|---|---|---|
Market Cap | 3.36T | 651.75B |
Volume | 31.7K | 848.2K |
Lot | 317 | 8.48K |
Turnover | 27.04M | 140.51M |
Average Price | 853.01 | 165.66 |
Value | 27.04M | 140.51M |
Indicative Equilibrium Price | 840 | 168 |
Indicative Equilibrium Volume | 100 | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indomobil Sukses Internasional Tbk.
PT Indomobil Sukses International Tbk (the Company) was initially established as a result of the merger between PT Indomulti Inti Industri Tbk (IMII) and PT Indomobil Investment corporation (IIC). The Company’s articles of association has been amended from time to time, most recently on June 30, 1999 in connection with the Company’s plans to offer shares with pre-emptive right. The Ministry of Justice has approved the amendment on July 5, 1999.
Read more on IMAS →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
